Streetwise Healthcare Services Articles


Portfolio Manager's Biotech Watchlist Picks for 2018

  ()
StoneCastle Investment Management has a high-growth fund that invests wherever it finds opportunities, and it is bullish on healthcare. In this interview with The Life Sciences Report, portfolio manager Bruce Campbell highlights four companies that he is putting on Streetwise Reports' 2018 Biotech Watchlist. read more >

Exploring Solutions to Healthcare's Spending Crisis

Contributed Opinion
Source: Dr. Len Yaffe for The Life Sciences Report  (10/19/2016)
Exploring Solutions to Healthcare's Spending Crisis
Rising healthcare costs continue to preoccupy providers, patients, politicians and investors. Some cost increases stem from inefficiencies in the medical system, some from social and demographic trends, and others are a function of profit motives on the part of insurers and a few drug companies. In this article for The Life Sciences Report, Dr. Len Yaffe of Stoc*Doc Partners reviews the issues and proposes some cures. read more >

Nobilis Moves Forward with New President and New Canaccord Coverage

Source: The Life Sciences Report  (07/20/2016)
Nobilis Moves Forward with New President and New Canaccord Coverage
Under the guidance of newly appointed president Kenneth Efird, Nobilis Health Corp. plans to continue to roll out new products and optimize its marketing strategy. read more >
Management Q&A: View from the Top

How Nobilis Health Will Break Out of the Healthcare Payment Mold

Managment Q&A: View from the Top
Source: George S. Mack of The Life Sciences Report   (05/25/2016)
How Nobilis Health Will Break Out of the Healthcare Payment Mold
Managing both acquisitions and internal growth at the same time is difficult for most small companies, but not for Nobilis Health Corp., which is orchestrating the flow of new patients to its ambulatory surgical centers while it adds an ensemble of new clinics, resulting in harmonious revenue. read more >
Management Q&A: View from the Top

Moseda Joins Telus and Apple in the $20B Patient Home Monitoring Sector

Managment Q&A: View from the Top
Source: Special to The Life Sciences Report  (03/29/2016)
Moseda Joins Telus and Apple in the $20B Patient Home Monitoring Sector
Moseda Technologies has developed innovative, secure mobile software solutions for the $20 billion community/home care market. In this interview, Moseda CEO Dr. Lisa Crossley describes the company's comprehensive hardware and software solution, dubbed CareKit, which allows patients to receive high-quality care in the home while reducing the cost of care. read more >
Management Q&A: View from the Top

Nobilis Health Doubles Down, Offering Organic Growth and Aggressive Acquisitions: Kolin Ozonian

Managment Q&A: View from the Top
Source: George S. Mack of The Life Sciences Report  (03/23/2016)
Nobilis Health Doubles Down, Offering Organic Growth and Aggressive Acquisitions: Kolin Ozonian
Businesses can grow in two ways—internally and externally. Nobilis Health Corp. has a voracious appetite for both. The company is a development and management firm that acquires private outpatient surgical centers—in short, it's a business model built on efficiencies. Nobilis scans the market for clinics that can be acquired and scaled up using sophisticated direct marketing approaches. read more >

The Academic Approach to Biotech Stocks: Alan Leong of BioWatch News

Source: George S. Mack of The Life Sciences Report  (01/20/2016)
The Academic Approach to Biotech Stocks: Alan Leong of BioWatch News
Combining academic discipline with methodical due diligence, Alan Leong of BioWatch News undertakes a regimented review of each biotech and medtech stock he investigates. Each company carries its own risks, but every stock has a special growth story that could propel huge gains if data fall into place. read more >

A Bucket of Canadian Stocks Set to Soar in 2016: Euro Pacific Canada's Doug Loe

Source: Staff of The Life Sciences Report  (01/13/2016)
A Bucket of Canadian Stocks Set to Soar in 2016: Euro Pacific Canada's Doug Loe
Canadian healthcare stocks offer a windbreak for biotech investors in a turbulent market, especially if they select a diversified basket across the various sectors, says Euro Pacific Canada's Doug Loe. read more >

Growth by Acquisition Is Solid: Russell Stanley of Mackie Research Capital

Source: George S. Mack of The Life Sciences Report   (12/23/2015)
Growth by Acquisition Is Solid: Russell Stanley of Mackie Research Capital
Russell Stanley of Mackie Research Capital tells investors that growth is where you find it, including in acquisitions, and that capital can be deployed to leverage the healthcare market via reimbursement from Medicare, the Affordable Care Act and private-pay insurance. read more >
Showing Results: 1 to 9 of 9

Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe